Gene Targeting in Hematopoietic Stem Cells for Basic and Translational Research

In this webinar Dr Daniel Dever, Stanford University, describes a reproducible CRISPR-Cas9-based protocol for gene editing in hematopoietic stem cells.
Publish Date: November 28, 2018